Company
Baebies
Multifunctional Testing – One Platform, Multiple Types of Tests, Delivering Rapid Results for Near-Patient Use.
Also known as Baebies, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Durham, NC, United States
- Customers
- hospitals, clinics, pharmacies, and decentralized care settings
- Legal name
- Baebies, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Baebies pioneered multifunctional syndromic testing, unfolding new possibilities in rapid, versatile, and accessible diagnostics. Powered by proprietary digital microfluidics technology, Baebies’ approach integrates multiple testing modalities—molecular, immunoassay, chemistry, and coagulation—into a single, compact platform, eliminating the need for separate instruments for each diagnostic function.
Funding snapshot
- Total raised
- $92.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series B, $10M2017-10-31
Funding rounds
- Round, 2025
- $2M2025-09-04, SEC form D sold, 24 investors
- Round, 2022
- $37.6M2022-04-15, SEC form D sold, 87 investors
- Round, 2021
- $11.9M2021-05-28, SEC form D sold, 87 investors
- Series B
- $10M2017-10-31, Company stated
- Round, 2016
- $28.3M2016-12-30, SEC form D sold, 173 investors
- Round, 2015
- $13M2015-07-28, Company stated
- Round, 2013
- $13M2013-08-29, SEC form D sold, 94 investors
Products
- Web
- FINDER Anti-Factor Xa Test
- Web
- FINDER Flu A/Flu B/SARS-CoV-2 Test
- Web
- FINDER G6PD Test
- Hardware
- FINDER Multifunctional Diagnostic Platform
- Web
- FINDER Multifunctional Diagnostic Platform
Loading relationship preview